| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0006 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.095 | 0.001 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.002 |